Mercados/AccionesArticle

Enhertu receives EU committee backing for early breast cancer

Enhertu has been backed by an EU committee for use in early breast cancer, according to the announcement.

PA

Priya Anand · Equities & Earnings Desk · 21 Sept 2026 · 06:26 · 1 min de lectura

Enhertu receives EU committee backing for early breast cancer

Enhertu received backing from an EU committee for early breast cancer.

Further verified details were not immediately available.

Equities

Este artículo fue producido con asistencia de IA y editado por un periodista de Finance Review Daily.

Novara — A Smarter Way to Access Global Markets

Compartir esta noticia

PA

Escrito por

Priya Anand

Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

Más de Priya Anand →

Panorama del mercado

Con retraso

EUR/USD1.1482▼ 0.03%GBP/USD1.3386▼ 0.05%USD/CHF0.8230▲ 0.05%BTC/USD81,490▲ 0.38%ETH/USD2,659.44▲ 0.54%XAU/USD4,378.25▼ 0.04%

Enhertu receives EU committee backing for early breast cancer

Panorama del mercado

Lecturas relacionadas

OTE Buys Back Nearly 300,000 Shares for €5.9 Million

ICU Medical Shifts Focus to Cash Returns Amid Growth Stability

ALX Oncology Details Biomarker Strategy for CD47 Program at Cantor Conference

Pennant International raises £400k short-term loan from shareholder

Pulsar Helium names David Young as CFO and director